Chitosan Nanoparticles Containing Cinnamomum verum J.Presl Essential Oil and Cinnamaldehyde; Preparation, Characterization and Anticancer Effects Against Melanoma and Breast Cancer Cells

  • Kamyar Khoshnevisan Biosensor Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, 1411713137, Iran
  • Hiva Alipanah Department of Physiology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
  • Hadi Baharifar Department of Medical Nanotechnology, Applied Biophotonics Research Center, Science and Research Branch, Islamic Azad University, Tehran, 1477893855, Iran
  • Negar Ranjbar Department of Medicine, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
  • Mahmoud Osanloo Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran
Keywords: Chitosan; Cinnamaldehyde; Cinnamomum zeylanicum Blume; Essential oils; Anticancer activity

Abstract

Cancer is the second leading cause of death worldwide, and due to the emergence of resistance to synthetic drugs in different cancers, developing new green drugs have become crucial. In this study, chitosan nanoparticles containing Cinnamomum verum J.Presl essential oil and cinnamaldehyde (major ingredient) were first prepared. The obtained nanoparticles were then characterized using Dynamic Light Scattering (DLS), Transmission electron microscopy (TEM), and Attenuated Total Reflection-Fourier Transform InfraRed (ATR-FTIR). After that, anticancer effects of the as-prepared nanoparticles were investigated. IC50 values of chitosan nanoparticles containing the essential oil were observed at 79 and 112 µg/mL against A-375 and MDA-MB-468 cells, respectively. These values for chitosan nanoparticles containing cinnamaldehyde were obtained at 135 and 166 µg/mL. The results of the current study indicated that chitosan nanoparticles containing C. verum essential oil can inhibit the growth of human melanoma (A-375) and breast cancer (MDA-MB-468) cells.

Published
2022-03-29
Section
Articles